Светлана Владимировна Туркина
Volgograd State Medical University · 172 works · 420 citations · h-index 10
Top works
- Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version
- Constipation in adults
- RECOMMENDATIONS ON MANAGEMENT OF PRIMARY CARE PATIENTS WITH SYMPTOMS OF DYSPEPSIA
- ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM
- New data on well-known drug: focus on meldonium
- Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines
- [Use of meldonium in the combination treatment of patients with heart failure in the early postinfarction period].
- Helicobacter pylori, helicobacteriosis and associated diseases (VIII Moscow Agreements on the diagnosis and treatment of helicobacteriosis in adults and children) A Clinical Guide for Physicians
- Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
- RECOMMENDATIONS FOR THE PREVENTION AND TREATMENT OF ESOPHAGO- GASTRO- ENTERO-COLOPATHY INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS “NSAID”
- Clinical guidelines “Chronic diarrhea in adults”
- NAFLD Associated Comorbidity
- Mildronate effects on cognitive function in elderly patients with arterial hypertension
- [Mildronate effects on oxidant stress in type 2 diabetic patients with diabetic peripheral (sensomotor) neuropathy].
- Enterohepatocentrism as the basis of human psychosomatic pathology
- Recommendations for prevention and treatment of Esophago-Gastro-Entero-Colopathies induced by non-steroid anti-inflammatory drugs (NSAIDs) - 2025
- [Additional advantages of mexicor used in combined therapy of coronary heat disease and diabetes mellitus of 2nd type].
- VISCERAL OBESITY AS A RISK MARKER OF MULTIORGAN DAMAGE
- MILDRONATE THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE, TYPE 2 DIABETES MELLITUS AND AUTONOMOUS CARDIAC NEUROPATHY
- Hyperammonemia in adults - 2025. Practical recommendations